Carlotta01 https://www.nct-dresden.de/en/trials/900-000002302 https://www.nct-dresden.de/@@site-logo/logo-nct.svg Carlotta01 Category Hematological neoplasms Subcategory Non-Hodgkin lymphoma, Multiple myeloma Trial Type other systemic therapies Description for experts A Phase I trial to establish the safety and maximum tolerated dose of high-affinity autologous BCMA- targeting CAR-T cells in patients with relapsed and refractory B-cell malignancies Description for laymen
